Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay

S Conway, S J Canning, H E Howell, E S Mowat, Perry Barrett, Janice Drew, P Delagrange, D Lesieur, Peter John Morgan

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

A cyclic AMP response element (CRE)-luciferase reporter gene assay was used to characterise the functional responses of human melatonin mt(1) and human melatonin MT2 receptors, stably expressed in the human embryonic kidney cell line HEK293, to a series of six naphthalenic analogues of melatonin. By comparison to the observed melatonin-mediated inhibition of stimulated luciferase levels the naphthalenic series was identified as comprising agonists, partial agonists and one antagonist of melatonin mt(1) and melatonin MT2 receptor function. Three of the agonist/partial agonist members of this series were also identified as displaying a functional selectivity for the melatonin MT2 receptor. Competitive displacement of 2-[I-125]iodomelatonin binding to the ovine pars tuberalis melatonin ML1 receptor demonstrated a close correlation to the observed functional luciferase responses of the human melatonin mt(1) receptor. We conclude that the CRE-luciferase reporter gene assay provides an effective functional screening method for the pharmacological characterisation of human melatonin receptor subtypes. (C) 2000 Elsevier Science B.V. All rights reserved.

Original languageEnglish
Pages (from-to)15-24
Number of pages10
JournalEuropean Journal of Pharmacology
Volume390
Issue number1-2
DOIs
Publication statusPublished - 25 Feb 2000

Keywords

  • melatonin receptor
  • cAMP response element
  • luciferase
  • reporter gene assay
  • HEK293 cell
  • ovine pars tuberalis
  • naphthalenic ligands
  • high-affinity
  • cloning
  • expression
  • inhibition
  • MEL(1A)
  • gene
  • pharmacology
  • localization

Cite this

Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay. / Conway, S ; Canning, S J ; Howell, H E ; Mowat, E S ; Barrett, Perry; Drew, Janice; Delagrange, P ; Lesieur, D ; Morgan, Peter John.

In: European Journal of Pharmacology, Vol. 390, No. 1-2, 25.02.2000, p. 15-24.

Research output: Contribution to journalArticle

Conway, S ; Canning, S J ; Howell, H E ; Mowat, E S ; Barrett, Perry ; Drew, Janice ; Delagrange, P ; Lesieur, D ; Morgan, Peter John. / Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay. In: European Journal of Pharmacology. 2000 ; Vol. 390, No. 1-2. pp. 15-24.
@article{edb80f98430a497089b4d7f18d816704,
title = "Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay",
abstract = "A cyclic AMP response element (CRE)-luciferase reporter gene assay was used to characterise the functional responses of human melatonin mt(1) and human melatonin MT2 receptors, stably expressed in the human embryonic kidney cell line HEK293, to a series of six naphthalenic analogues of melatonin. By comparison to the observed melatonin-mediated inhibition of stimulated luciferase levels the naphthalenic series was identified as comprising agonists, partial agonists and one antagonist of melatonin mt(1) and melatonin MT2 receptor function. Three of the agonist/partial agonist members of this series were also identified as displaying a functional selectivity for the melatonin MT2 receptor. Competitive displacement of 2-[I-125]iodomelatonin binding to the ovine pars tuberalis melatonin ML1 receptor demonstrated a close correlation to the observed functional luciferase responses of the human melatonin mt(1) receptor. We conclude that the CRE-luciferase reporter gene assay provides an effective functional screening method for the pharmacological characterisation of human melatonin receptor subtypes. (C) 2000 Elsevier Science B.V. All rights reserved.",
keywords = "melatonin receptor, cAMP response element, luciferase, reporter gene assay, HEK293 cell, ovine pars tuberalis, naphthalenic ligands, high-affinity, cloning, expression, inhibition, MEL(1A), gene, pharmacology, localization",
author = "S Conway and Canning, {S J} and Howell, {H E} and Mowat, {E S} and Perry Barrett and Janice Drew and P Delagrange and D Lesieur and Morgan, {Peter John}",
year = "2000",
month = "2",
day = "25",
doi = "10.1016/S0014-2999(99)00914-0",
language = "English",
volume = "390",
pages = "15--24",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Characterisation of human melatonin mt(1) and MT2 receptors by CRE-luciferase reporter assay

AU - Conway, S

AU - Canning, S J

AU - Howell, H E

AU - Mowat, E S

AU - Barrett, Perry

AU - Drew, Janice

AU - Delagrange, P

AU - Lesieur, D

AU - Morgan, Peter John

PY - 2000/2/25

Y1 - 2000/2/25

N2 - A cyclic AMP response element (CRE)-luciferase reporter gene assay was used to characterise the functional responses of human melatonin mt(1) and human melatonin MT2 receptors, stably expressed in the human embryonic kidney cell line HEK293, to a series of six naphthalenic analogues of melatonin. By comparison to the observed melatonin-mediated inhibition of stimulated luciferase levels the naphthalenic series was identified as comprising agonists, partial agonists and one antagonist of melatonin mt(1) and melatonin MT2 receptor function. Three of the agonist/partial agonist members of this series were also identified as displaying a functional selectivity for the melatonin MT2 receptor. Competitive displacement of 2-[I-125]iodomelatonin binding to the ovine pars tuberalis melatonin ML1 receptor demonstrated a close correlation to the observed functional luciferase responses of the human melatonin mt(1) receptor. We conclude that the CRE-luciferase reporter gene assay provides an effective functional screening method for the pharmacological characterisation of human melatonin receptor subtypes. (C) 2000 Elsevier Science B.V. All rights reserved.

AB - A cyclic AMP response element (CRE)-luciferase reporter gene assay was used to characterise the functional responses of human melatonin mt(1) and human melatonin MT2 receptors, stably expressed in the human embryonic kidney cell line HEK293, to a series of six naphthalenic analogues of melatonin. By comparison to the observed melatonin-mediated inhibition of stimulated luciferase levels the naphthalenic series was identified as comprising agonists, partial agonists and one antagonist of melatonin mt(1) and melatonin MT2 receptor function. Three of the agonist/partial agonist members of this series were also identified as displaying a functional selectivity for the melatonin MT2 receptor. Competitive displacement of 2-[I-125]iodomelatonin binding to the ovine pars tuberalis melatonin ML1 receptor demonstrated a close correlation to the observed functional luciferase responses of the human melatonin mt(1) receptor. We conclude that the CRE-luciferase reporter gene assay provides an effective functional screening method for the pharmacological characterisation of human melatonin receptor subtypes. (C) 2000 Elsevier Science B.V. All rights reserved.

KW - melatonin receptor

KW - cAMP response element

KW - luciferase

KW - reporter gene assay

KW - HEK293 cell

KW - ovine pars tuberalis

KW - naphthalenic ligands

KW - high-affinity

KW - cloning

KW - expression

KW - inhibition

KW - MEL(1A)

KW - gene

KW - pharmacology

KW - localization

U2 - 10.1016/S0014-2999(99)00914-0

DO - 10.1016/S0014-2999(99)00914-0

M3 - Article

VL - 390

SP - 15

EP - 24

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -